Log in

OTCMKTS:OSIR - Osiris Therapeutics Stock Price, Forecast & News

$18.99
0.00 (0.00 %)
(As of 04/17/2019)
Today's Range
$18.99
Now: $18.99
$18.99
50-Day Range
$18.99
MA: $18.99
$18.99
52-Week Range
$7.01
Now: $18.99
$19.30
VolumeN/A
Average Volume202,293 shs
Market Capitalization$655.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Osiris Therapeutics, Inc researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Current SymbolOTCMKTS:OSIR
Previous SymbolNASDAQ:OSIR
CUSIP68827R10
Phone443-545-1800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$655.69 million
Next Earnings DateN/A
OptionableOptionable

Receive OSIR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSIR and its competitors with MarketBeat's FREE daily newsletter.


Osiris Therapeutics (OTCMKTS:OSIR) Frequently Asked Questions

What is Osiris Therapeutics' stock symbol?

Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR."

Has Osiris Therapeutics been receiving favorable news coverage?

Press coverage about OSIR stock has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Osiris Therapeutics earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Osiris Therapeutics.

Who are some of Osiris Therapeutics' key competitors?

What other stocks do shareholders of Osiris Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR), MiMedx Group (MDXG), Achillion Pharmaceuticals (ACHN), Fate Therapeutics (FATE), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Cytokinetics (CYTK), Depomed (DEPO), EXACT Sciences (EXAS) and Exelixis (EXEL).

Who are Osiris Therapeutics' key executives?

Osiris Therapeutics' management team includes the folowing people:
  • Mr. Jason Keefer, Interim Pres & CEO (Age 46)
  • Dr. Alla N. Danilkovitch, Chief Scientific Officer (Age 54)
  • Mr. Joel David Rogers, Interim Chief Financial Officer (Age 56)
  • Mr. Edward Yip, Chief Legal Officer & Corp. Sec.
  • Mr. Laine Dyess, VP of Sales

How do I buy shares of Osiris Therapeutics?

Shares of OSIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Osiris Therapeutics' stock price today?

One share of OSIR stock can currently be purchased for approximately $18.99.

How big of a company is Osiris Therapeutics?

Osiris Therapeutics has a market capitalization of $655.69 million. View Additional Information About Osiris Therapeutics.

What is Osiris Therapeutics' official website?

The official website for Osiris Therapeutics is http://www.osiristx.com/.

How can I contact Osiris Therapeutics?

Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The biotechnology company can be reached via phone at 443-545-1800 or via email at [email protected]


MarketBeat Community Rating for Osiris Therapeutics (OTCMKTS OSIR)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  116 (Vote Outperform)
Underperform Votes:  172 (Vote Underperform)
Total Votes:  288
MarketBeat's community ratings are surveys of what our community members think about Osiris Therapeutics and other stocks. Vote "Outperform" if you believe OSIR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSIR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel